BR112022021418A2 - Métodos e composições para inibição de vírus envelopados com o uso de polímeros hidrofobicamente modificados de baixo peso molecular - Google Patents

Métodos e composições para inibição de vírus envelopados com o uso de polímeros hidrofobicamente modificados de baixo peso molecular

Info

Publication number
BR112022021418A2
BR112022021418A2 BR112022021418A BR112022021418A BR112022021418A2 BR 112022021418 A2 BR112022021418 A2 BR 112022021418A2 BR 112022021418 A BR112022021418 A BR 112022021418A BR 112022021418 A BR112022021418 A BR 112022021418A BR 112022021418 A2 BR112022021418 A2 BR 112022021418A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
molecular weight
low molecular
enveloped viruses
Prior art date
Application number
BR112022021418A
Other languages
English (en)
Inventor
Bruning Elizabeth
Capone Kimberly
Gandolfi Lisa
Robert Geonnotti Anthony
Thomas Ekman-Gunn Euen
Roshek Johnson Diana
J Kirchner Frank
Moses Selina
Santora Delores
Walters Russel
C Sun Frank
Original Assignee
Johnson & Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Inc filed Critical Johnson & Johnson Consumer Inc
Publication of BR112022021418A2 publication Critical patent/BR112022021418A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

MÉTODOS E COMPOSIÇÕES PARA INIBIÇÃO DE VÍRUS ENVELOPADOS COM O USO DE POLÍMEROS HIDROFOBICAMENTE MODIFICADOS DE BAIXO PESO MOLECULAR. A presente invenção se refere a métodos e composições para inibição da transmissão de vírus envelopados, que envolvem a aplicação de uma composição contendo um polímero hidrofobicamente modificado de baixo peso molecular a uma superfície infectável ou ingerível que pode conter vírus e em que a dita composição é substancialmente isenta de tensoativos com um ELH maior que 12.
BR112022021418A 2020-04-23 2021-04-19 Métodos e composições para inibição de vírus envelopados com o uso de polímeros hidrofobicamente modificados de baixo peso molecular BR112022021418A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/856,735 US20210330698A1 (en) 2020-04-23 2020-04-23 Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
PCT/IB2021/053202 WO2021214624A1 (en) 2020-04-23 2021-04-19 Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers

Publications (1)

Publication Number Publication Date
BR112022021418A2 true BR112022021418A2 (pt) 2022-12-13

Family

ID=75660100

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022021418A BR112022021418A2 (pt) 2020-04-23 2021-04-19 Métodos e composições para inibição de vírus envelopados com o uso de polímeros hidrofobicamente modificados de baixo peso molecular

Country Status (9)

Country Link
US (1) US20210330698A1 (pt)
EP (1) EP4138799A1 (pt)
KR (1) KR20230004737A (pt)
CN (1) CN115916169A (pt)
AU (1) AU2021260165A1 (pt)
BR (1) BR112022021418A2 (pt)
CA (1) CA3175080A1 (pt)
MX (1) MX2022013337A (pt)
WO (1) WO2021214624A1 (pt)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6433061B1 (en) 2000-10-24 2002-08-13 Noveon Ip Holdings Corp. Rheology modifying copolymer composition
US7892525B2 (en) 2003-08-22 2011-02-22 Lubrizol Advanced Materials, Inc. Antiperspirant gel compositions
US7157414B2 (en) 2003-08-28 2007-01-02 J&J Consumer Companies, Inc. Methods of reducing irritation in personal care compositions
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
US20050244365A1 (en) * 2004-05-03 2005-11-03 Novaflux Biosciences, Inc. Methods, compositions, formulations, and uses of cellulose and acrylic-based polymers
US7803403B2 (en) 2006-11-09 2010-09-28 Johnson & Johnson Consumer Companies, Inc. Low-irritation compositions and methods of making the same
BRPI0718034A8 (pt) 2006-11-09 2017-12-19 Lubrizol Advanced Mat Inc Métodos para aumentar a concentração crítica de micelas de uma composição de tensoativo e de uma composição detersiva de cuidado industrial e institucional, de cuidado doméstico, de cuidado de animais de estimação e de cuidado de animais
US8329626B2 (en) 2010-06-24 2012-12-11 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
US8343902B2 (en) 2010-06-24 2013-01-01 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
US8329627B2 (en) 2010-06-24 2012-12-11 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
US9068148B2 (en) 2010-07-09 2015-06-30 Lubrizol Advanced Materials, Inc. Blends of acrylic copolymer thickeners
BR112013007955B1 (pt) 2010-10-05 2018-08-07 Lubrizol Advanced Materials, Inc. Composição de tensoativo, composição de limpeza de cuidado pessoal, e, método para espessar um tensoativo aquoso
CN104994889B (zh) * 2013-02-19 2017-04-26 强生消费者公司 用于改善疤痕组织的外观和形成的方法及组合物
US10435308B2 (en) 2013-03-08 2019-10-08 Ecolab Usa Inc. Enhanced foam fractionation of oil phase from aqueous/oil mixed phase via increased viscoelasticity
US20150272124A1 (en) 2014-03-25 2015-10-01 Ecolab Usa Inc. Antimicrobial compositions containing cationic active ingredients
US9956153B2 (en) 2014-08-01 2018-05-01 Ecolab Usa Inc. Antimicrobial foaming compositions containing cationic active ingredients

Also Published As

Publication number Publication date
KR20230004737A (ko) 2023-01-06
WO2021214624A1 (en) 2021-10-28
CA3175080A1 (en) 2021-10-28
EP4138799A1 (en) 2023-03-01
US20210330698A1 (en) 2021-10-28
CN115916169A (zh) 2023-04-04
AU2021260165A1 (en) 2023-01-05
MX2022013337A (es) 2023-02-15

Similar Documents

Publication Publication Date Title
BR112014032673A2 (pt) composição, composição reticulada e artigo
BR112014032139A2 (pt) composições da metátese de óleo natural
BR112013028790A2 (pt) composições de poliolefinas macias altamente preenchidas
BR112015017062A2 (pt) revestimento para substrato
BR112012021405A2 (pt) inibidor de contaminação
BR112018010717A8 (pt) composição de polímero à base de propileno
BR112018077402A2 (pt) composições à base de etileno/alfa-olefina/polieno
BR112012029566A2 (pt) composição.
BR112016014939A2 (pt) composição de polietileno e seu uso, artigo
BR112018012155A2 (pt) revestimento antibioincrustação baseado em resina epóxi e polissiloxano amina-funcional
BR112017011830A2 (pt) composição e processo para a maquiagem
BR112016018667A2 (pt) Composição de combustível marinho
BR112014016220A2 (pt) composição e artigo
BR112018001587A2 (pt) composições elásticas à base de poliolefina, métodos de fabricação das mesmas e artigos compreendendo as mesmas
BR112017002569A2 (pt) composições adesivas compreendendo polímeros à base de olefina funcionalizados de baixo peso molecular
BR112022001608A2 (pt) Composições de copolímero reticulável e de tinta, objeto revestido, e, qualquer objeto
BR112022015264A2 (pt) Formulação pesticida
BR112022021418A2 (pt) Métodos e composições para inibição de vírus envelopados com o uso de polímeros hidrofobicamente modificados de baixo peso molecular
BR112022022440A2 (pt) Composição polimérica, e, condutor revestido
BR112017028455A2 (pt) composições de polímeros à base de etileno para revestimentos de extrusão melhorados
BR112018069115A2 (pt) composições, composições de revestimento aquosas e métodos para melhorar a estabilidade de congelamento/descongelamento de composições de revestimento aquosas
BR112022021401A2 (pt) Métodos para inibir vírus envelopados com o uso de polímeros hidrofobicamente modificados de baixo peso molecular
BR112022021430A2 (pt) Métodos e composições para inibição de vírus envelopados com o uso de polímeros hidrofobicamente modificados de alto peso molecular
BR112019000905A2 (pt) composições de inundação que compreendem fluidos de base biológica
BR112022021467A2 (pt) Métodos e composições para inibição de vírus envelopados com o uso de polímeros hidrofobicamente modificados de alto peso molecular

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing